Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Clinical trial NCT00424255 · COMPLETED

Trial details

NCT number: NCT00424255
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Head and Neck

Start date: 2006-12-01
Primary completion: 2013-03-01
Enrollment: 688

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.